Is InMode's Effectiveness Really Proven by Research? A Review of the Evidence and Korean Approval Status

Key summary. InMode is not the name of a single procedure. It is a device brand that covers several handpieces and energy methods. This article focuses on Morpheus8 (Morpheus8), which uses microneedles to deliver bipolar radiofrequency (RF) energy into the skin. In Korea, we confirmed that the Morpheus8 handpiece and tips are listed as components under Import permit 19-352 from the Ministry of Food and Drug Safety (MFDS). The item name on this permit is general-purpose electrosurgical unit, and the representative model name is Inmode RF. A 2026 systematic review of RF microneedling pooled 20 studies with 558 participants, but only one of those studies used Morpheus8, and it had 9 participants. For this reason, results for RF microneedling as a whole cannot be presented as proof that the InMode brand works.

What this article covers

• Comparison criteria: the actual handpiece, the energy method, the components covered by the Korean permit, and the difference between brand-specific evidence and evidence for the broader technology category
• Cautions: in 2025, the FDA issued a notice about reports of serious complications with some uses of RF microneedling, including burns, scarring, fat loss, and nerve damage
• Evidence status: we checked 2 brand-specific original papers, 1 systematic review of RF microneedling, the FDA safety notice, and Korean permit documents

Key points

1. Definition: Morpheus8 is an RF microneedling device. It inserts microneedle electrodes into the skin and then delivers bipolar radiofrequency heat at a target depth.
2. Interpreting the evidence: A recent review of the category covers 20 studies with 558 participants, but the devices and indications vary widely. Only one of those studies, with 9 participants, looked at Morpheus8 itself, so the effect of this brand alone is hard to establish.
3. What to check, in order: the actual handpiece and its permit number → the practitioner's qualifications and training → the reasons for the chosen depth and energy settings → the procedures for pain, recovery, and serious complications.

01How does it work?

Morpheus8 inserts multiple fine needles into the skin and passes bipolar radiofrequency energy between the electrodes. This creates zones of heat coagulation at a target depth. The basic principle of RF microneedling is that the skin reorganizes collagen as it heals from these micro-injuries and the heat stimulation. However, the "InMode" name also covers other handpieces, so during a consultation you should first confirm whether the treatment uses Morpheus8 or a different mode. If research and risks from different handpieces are combined as though they were one procedure, the evidence no longer applies in the same way.

The Korean approval is Import permit 19-352. Its details are: item name general-purpose electrosurgical unit, Class 3, approval date 2019-10-30, importer Shinhan Networks Co., Ltd., manufacturing requester Inmode Ltd., and manufacturer Flextronics Ltd.. When we first searched the permit database, brand names such as "InMode" and "Morpheus" returned no results. This is because the representative model name registered with the MFDS is Inmode RF. Morpheus8 does not have its own model record. Instead, the public attachments to this permit list it as a handpiece (model AS607401A) together with 24pin, T (Resurfacing), and 12pin tips as parts. In other words, this is not a "standalone Morpheus8 approval." It is an approval for the Inmode RF system, which includes Morpheus8 as a component. It is also a separate question whether the device at the clinic you visit is the one covered by this permit. Each clinic may have bought its device at a different time and may use a different set of handpieces. The accurate way to check is to compare the label on the clinic's device with this permit number during your consultation.

02What the research does and does not show

The above values are based on a full reading of the original texts of 2026-09-26. The most recent literature review concluded that improvements were generally reported across the category as a whole. However, the studies differed so much that their figures could not be pooled into a single number, and the review also pointed to possible publication bias toward positive results. Because follow-up periods were short, the review noted that long-term durability and late-onset adverse reactions are hard to judge. Studies with fewer than 30 participants are strongly affected by individual variation and chance. In particular, the 9-participant study that included Morpheus 8 and the 2-patient cellulite case series should not be used to generalize about effect size or complication rates.

Conflicts of interest also need to be considered. In the 2026 literature review, the first and corresponding author and one co-author disclosed employment with, or speaking roles for, Jeisys Medical, which makes a different RF device. The author of the 2022 review of Morpheus 8 for the face disclosed an advisory relationship with InMode. A disclosed conflict of interest does not by itself mean the results are wrong, but it is still necessary to check whether independent studies have repeated the same results.

03What to check before the procedure

04Choosing by situation

• You want no incisions and a short recovery → Discuss it in consultation alongside other non-surgical lifting options (Ulthera, Thermage, Shrink, etc.)
• You are concerned about skin texture issues such as pores or scars → Confirm in consultation that InMode uses a microneedling method, which works differently from devices that only heat the skin surface
• You place a high value on evidence → Keep in mind that brand-specific evidence is limited, and ask the practitioner for specific data

05Common misconceptions

"If there are 20 papers on RF microneedling, InMode must be well proven": A technology category and a brand are not the same thing. Of the 20 studies and 558 participants in the 2026 literature review, only one study, with 9 participants, was on Morpheus 8. Results that pool devices from several companies and different indications should not be presented as evidence of a specific brand's effectiveness.

"The manufacturer's website lists papers, so it has been independently verified": Being published in a journal is not the same as having no conflict of interest with the manufacturer. The author of the 2022 facial review disclosed an advisory relationship with InMode, and the cellulite paper on the manufacturer's site was a case series of 2 women with no control group.

"It's non-surgical, so there are no serious side effects": In 2025, the FDA announced that it had received reports of serious complications with some uses of RF microneedling, including burns, scarring, fat loss, disfigurement, and nerve damage. The communication did not give incidence rates, so it cannot be said that these risks are common, but this is also not a decision to make after being told only about simple swelling and bruising.

"If a brand-name search turns up nothing, the device has no Korean approval": This article itself initially failed to find a Korean approval using the search terms "InMode" and "Morpheus." That was because the representative model name registered with the Ministry of Food and Drug Safety was Inmode RF, not the brand name, and Morpheus 8 was listed in the attached documents only as a component (handpiece and tip) of that approval. A second check by product name then confirmed Import permit 19-352. This case shows that you should not draw conclusions from a brand-name search alone and should also check the representative model name and product name.

06In summary

The InMode brand name alone does not tell you which procedure you will actually receive. For Morpheus8, you can confirm the working principle (RF microneedling) and the configuration approved in Korea. However, the most recent systematic review found only one brand-specific study, with 9 participants, and long-term follow-up was lacking. At a consultation, check each of these separately: the actual handpiece and tip and their permit number, the reason for the chosen depth and energy settings, the practitioner's training, and the procedure for handling the serious complications the FDA has warned about. What matters more than "there is a study" is which device that study tested, on how many people, and for how long.

07Frequently Asked Questions

How does InMode work?

With Morpheus8, microneedle electrodes are inserted into the skin and deliver bipolar radiofrequency heat at a target depth. The small injuries and heat coagulation this causes are meant to trigger collagen remodeling as the skin heals. InMode includes several different handpieces, however, so at a consultation you should first confirm which device and mode will be used.

Has InMode been proven in research?

There is evidence for RF microneedling as a category, but it is too early to say that the effect of the InMode brand itself has been sufficiently confirmed by independent research. A 2026 systematic review included 20 studies and 558 participants, but only one Morpheus8 study, with 9 participants, and differences in devices and assessment methods meant a meta-analysis could not be performed. Brand-specific evidence and evidence for the technology category should be read separately.

Is InMode approved in Korea?

Yes. It is registered under Import permit 19-352 (product category: general-purpose electrosurgical unit; representative model name: Inmode RF), and Morpheus8 is listed in the package insert as a handpiece and tip component under this permit. You should still ask separately whether the equipment at the clinic you are consulting matches this permit.

Does InMode hurt?

There is no basis for saying it is painless. In a case series of two women treated for cellulite, one reported severe pain despite local anesthesia and inhaled sedation, and the other received tumescent anesthesia. Because this data comes from only two people, it does not indicate average pain levels, so ask specifically at your consultation about the tip, depth, anesthesia method, and criteria for stopping the procedure.

Are InMode, Ulthera, and Thermage the same procedure?

No, they are different procedures. Ulthera uses focused ultrasound, Thermage uses non-invasive monopolar radiofrequency, and Morpheus8 delivers bipolar radiofrequency through microneedle electrodes inserted into the skin. Because they differ in how energy is delivered and how invasive they are, their effects and risks should not be compared in a single line.

08Pre-consultation checklist

• □ I confirmed that the handpiece and tip configuration of the clinic's device matches the Korean permit (Import permit 19-352)
• □ I confirmed which medical professional will actually perform the procedure and their qualifications
• □ I checked whether the studies presented as evidence are independent research or sponsored supplement issues
• □ I received an explanation of pain, anesthesia methods, and the expected recovery period
• □ I received written information about side effects, including burns, scarring, fat loss, and nerve damage, and how they are managed

09Glossary

• RCT (randomized controlled trial): A study design that randomly assigns participants to groups for comparison; considered relatively reliable.

10Sources and verification date

• PMID 41947517·PMC13058395 — Full text read on 2026-09-26. A systematic review of RF microneedling for facial rejuvenation covering 20 studies and 558 participants (4 RCTs, 8 prospective studies, 8 case series). A meta-analysis could not be performed because the devices and assessment methods varied too much, and only 1 study, with 9 participants, looked at Morpheus8. Some authors disclosed that they are employed by Jeisys Medical or serve as its speakers.
• PMID 35916259 — Full text read on 2026-09-26. A narrative review of Morpheus8 use on the face, published in a special supplement (Suppl 1) of J Cosmet Dermatol in 10 2022. The author disclosed an advisory relationship with InMode.
• PMID 35907185 — Full text read on 2026-09-26. A case series of 2 women treated for cellulite with 2 sessions each, with no control group and no blinded assessment. One patient reported severe pain despite local anesthesia and inhaled sedation. Published in the same special supplement, and the PDF was checked on the manufacturer's website.
• FDA safety communication on RF microneedling — Checked on 2026-09-26. Communication dated 2025-10-15. It reported serious complications with some uses, including burns, scarring, fat loss, disfigurement, and nerve damage, but did not give incidence rates.
• FDA 510(k) clearances (submissions related to Morpheus8, e.g., K192695, K240017) — Checked on 2026-09-18 by searching the official database. These records confirm device registration and classification and are separate from Korean approval.
• Korean Ministry of Food and Drug Safety (MFDS) medical device approval Import permit 19-352 — Checked on 2026-09-19. We compared the product information, approval details, and public attachments (shape and structure, raw materials, directions for use, performance) directly and confirmed that the Morpheus8 handpiece and tips are components covered by this approval. A search by brand name did not find it because the representative model name is registered as Inmode RF.
• PubMed status recheck — 2026-09-26. None of PMID 41947517, 35916259, or 35907185 showed a linked retraction or correction notice.
• The studies above are materials for understanding how the procedure works and do not guarantee any particular clinic, practitioner, or outcome.

11Editorial responsibility and interests

• Written by: Korea Beauty Report Editorial Team · Editorial responsibility: Korea Beauty Report Editorial Team
• Review scope: The editorial team prepared this content from published research and public data. It was not separately reviewed by a medical professional and does not replace individual diagnosis or treatment.
• Conflicts of interest: No clinic mentioned in this article has a contract or advertising relationship with us
• First published: 2026-09-26, last source check: 2026-09-26